E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid

被引：18

作者：

Leroi, MJ ^{[1
]}

Siarakas, S ^{[1
]}

Gottlieb, T ^{[1
]}

机构：

[1] Concord Repatriat Gen Hosp, Dept Microbiol & Infect Dis, Sydney, NSW 2139, Australia

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2002年 / 21卷 / 01期

关键词：

D O I：

10.1007/s10096-001-0658-0

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：72 / 74

页数：3

共 13 条

[1]

Dresser LD, 1998, PHARMACOTHERAPY, V18, P456

[2] Antibiotic activity against genotypically distinct and indistinguishable Clostridium difficile isolates [J].

Freeman, J ;

Wilcox, MH .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (02) :244-246

[3] In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin [J].

Fung-Tomc, J ;

Minassian, B ;

Kolek, B ;

Washo, T ;

Huczko, E ;

Bonner, D .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (04) :437-446

[4] Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates [J].

Hoogkamp-Korstanje, JAA ;

Roelofs-Willemse, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) :31-39

[5]

Inagaki Yoshio, 1995, Japanese Journal of Antibiotics, V48, P368

[6] Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria [J].

Kato, N ;

Kato, H ;

Tanaka-Bandoh, K ;

Watanabe, K ;

Ueno, K .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) :631-637

[7] CLOSTRIDIUM-DIFFICILE COLITIS [J].

KELLY, CP ;

POTHOULAKIS, C ;

LAMONT, JT .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (04) :257-262

[8] SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO FCE-22101 [J].

NORD, CE ;

LINDMARK, A ;

PERSON, I .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (05) :831-833

[9]

PELAEZ T, 1998, 38 INT C ANT AG CHEM, P219

[10] In vitro activity of new generation fluoroquinolones against genotypically distinct and indistinguishable Clostridium difficile isolates [J].

Wilcox, MH ;

Fawley, W ;

Freeman, J ;

Brayson, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) :551-555

← 1 2 →